Log in
onclick="gourl('https://www.adsalecprj.com/en/auth/register.html')" v-if="!userInfo.id"> Register
Contact
{{userInfo.company_name_english||userInfo.truename_english}}
{{userInfo.phone||userInfo.email}}

Home Page

Member Center

Data Settings

Log out

 
Medical

Borealis’ renewable polyolefins cut Scope 3 emissions for lab filtration devices

Nov 11, 2025

Cytiva, a global leader in life sciences, has introduced Borealis’ ISCC PLUS-certified renewable polyolefins Bornewables into its lab filtration devices, reducing Scope 3 emissions while maintaining the high performance required for demanding healthcare applications.


Borealis_Bornewables for syringe filters.jpg


Cytiva has introduced Borealis’ Bornewables renewable polyolefins into its Whatman syringe filters.

 

Borealis’ Bormed portfolio, a specialized range of polyolefins developed specifically for healthcare applications, was chosen for Cytiva’s widely used Whatman Puradisc and GD/X filtration devices – sterile and non-sterile syringe filters that provide fast and efficient filtration.

 

The filtration device need to meet stringent performance standards, including the ability to withstand sterilization processes such as gamma irradiation. In addition, any renewable solution had to be a drop-in replacement, seamlessly fitting into existing production processes and fully compliant with the rigorous standards of the life sciences industry.

 

“At Cytiva, we know that the material choices we make directly influence our Scope 3 emissions. Introducing renewable resins into our filtration devices shows that we can reduce our footprint without compromising the performance and reliability our customers depend on. It’s an important step in our journey toward more sustainable laboratory solutions,” said Lacy Linney, Sustainability Product Transparency & Commercial Leader from Cytiva.

 

The Bornewables version of Bormed HD810MO, which is produced using renewable feedstock derived entirely from waste and residue streams, is used. The feedstock is ISCC PLUS-certified, ensuring full traceability from origin to resin, and Cytiva has achieved ISCC PLUS certification through to the final product, enabling verifiable sustainability claims.

 

The material also offers resistance to gamma sterilization and functions as a drop-in alternative to fossil-based resins, allowing Cytiva to maintain performance while reducing the environmental footprint of its products.

 

“This project is a strong example of how we collaborate across the value chain to deliver materials that combine uncompromising performance with verifiable sustainability benefits,” commented Martin Fraissler, Senior Application Marketing Manager Healthcare at Borealis.

Polyolefin
Medical
Borealis
Comments
Chemicals
This session delivers an in-depth analysis of real-world bottlenecks across six major downstream sectors: healthcare, circular PVC, film, cable, flooring, and compounding.
Sep 29, 2026
Injection
At Fakuma 2026, ENGEL will demonstrate the series production of auto-injector components on the all-electric e-mac 200, which combines an exceptionally small footprint with high output.
Sep 24, 2026
Medical
At Fakuma 2026, Kistler will put its MedRelease Suite at the center stage, providing complete, auditable quality documentation for medical technology.
Sep 18, 2026
Medical
The 8th Edition CPRJ Medical Plastics and Rubber Conference and Showcase was fruitfully held in Suzhou, China. Let’s see the highlights.
Sep 17, 2026
Medical
ROMIRA expands its portfolio with two advanced PA/ASA- and PC/PBT-based compounds, offering more high-performing material solutions for demanding medical technology applications.
Sep 9, 2026
Medical
SEM BIOTECH has established one of the world’s most precise and high-capacity vacuum blood collection tube production platforms, with an annual production capacity of 500 million tubes, under its Vacusem brand.
Aug 11, 2026
Share Your Choice
Facebook
X
Email